Another group pointed out that the treatment of AD-MSCs in Autoimmune Refractory Epilepsy resulted in increased angiogenin, CXCL12/SF1alfa I and IL-10 (interleukin 10) and decreased osteopontin levels (Szczepanik et al., 2020). Here, IL10 is linked to Alzheimer disease.